Physician Wealth Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.49K Hold
568
– – ﹤0.01% 1723
2026
Q2
$1.94K Hold
568
– – ﹤0.01% 1516
2026
Q1
$2.03K Hold
568
– – ﹤0.01% 1346
2025
Q4
$1.99K Sell
568
-594
-51% -$2.03K ﹤0.01% 1290
2025
Q3
$3.79K Buy
1,162
+672
+137% +$2.12K ﹤0.01% 999
2025
Q2
$1.2K Buy
490
+375
+326% +$1.9K ﹤0.01% 1274
2025
Q1
$768 Buy
115
+36
+46% +$356 ﹤0.01% 1248
2024
Q4
$994 Buy
+79
New +$1.19K ﹤0.01% 944

Other funds holding RCKT

Physician Wealth Advisors's RCKT Position: Q3 2026 in Review

Physician Wealth Advisors held its Rocket Pharmaceuticals (RCKT) position steady in Q3 2026 at 568 shares worth $1.49K. The position accounts for ﹤0.01% of the portfolio, ranked #1723.

Physician Wealth Advisors first reported a position in RCKT in Q4 2024 and has held it in 8 quarters since. The position peaked at $3.79K in Q3 2025. 175 funds tracked by Wall St. Rank hold RCKT as of Q3 2026.

  • Physician Wealth Advisors held 568 shares of Rocket Pharmaceuticals worth $1.49K as of Q3 2026.
  • Physician Wealth Advisors left its Rocket Pharmaceuticals share count unchanged in Q3 2026.
  • Rocket Pharmaceuticals made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #1723 holding.
  • Physician Wealth Advisors first reported a position in Rocket Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • Physician Wealth Advisors's Rocket Pharmaceuticals position peaked at $3.79K in Q3 2025.
  • 175 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.